XML 317 R37.htm IDEA: XBRL DOCUMENT
v3.23.1

Segment Information (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Segment Information [Abstract] |
Disclosure of operating segments | Information About Reportable Segments:
| 2022
| Internal $000s | Controlled Founded Entities $000s | Non-Controlled Founded Entities $000s | Parent Company & Other $000s | Consolidated $000s
Consolidated Statements of Comprehensive Income/(Loss) |  |  |  |  |
Contract revenue | — |  | 1,500 |  | 81 |  | 509 |  | 2,090 |
Grant revenue | 2,826 |  | 10,702 |  | — |  | — |  | 13,528 |
Total revenue | 2,826 |  | 12,202 |  | 81 |  | 509 |  | 15,618 |
General and administrative expenses | (8,301) |  | (16,462) |  | (1,296) |  | (34,933) |  | (60,991) |
Research and development expenses | (116,054) |  | (34,668) |  | (826) |  | (885) |  | (152,433) |
Total operating expense | (124,355) |  | (51,130) |  | (2,122) |  | (35,817) |  | (213,425) |
Other income/(expense): |  |  |  |  |
Gain on deconsolidation of subsidiary | — |  | — |  | — |  | 27,251 |  | 27,251 |
Gain/(loss) on investment held at fair value | — |  | — |  | — |  | (32,060) |  | (32,060) |
Realized loss on sale of investments | — |  | — |  | — |  | (29,303) |  | (29,303) |
Other income/(expense) | (204) |  | (3) |  | — |  | 8,338 |  | 8,131 |
Total other income/(expense) | (204) |  | (3) |  | — |  | (25,775) |  | (25,981) |
Net finance income/(costs) | 615 |  | 138,006 |  | (3,045) |  | 3,348 |  | 138,924 |
Share of net income/(loss) of associates accounted for using the equity method | — |  | — |  | — |  | (27,749) |  | (27,749) |
Gain on dilution of ownership interest in associate | — |  | — |  | — |  | 28,220 |  | 28,220 |
Impairment of investment in associate | — |  | — |  | — |  | (8,390) |  | (8,390) |
Income/(loss) before taxes | (121,118) |  | 99,075 |  | (5,085) |  | (65,655) |  | (92,783) |
Income/(loss) before taxes pre IFRS 9 fair value accounting, share-based payment expense, depreciation of tangible assets and amortization of intangible assets | (114,255) |  | (32,468) |  | (2,079) |  | (57,452) |  | (206,254) |
Finance income/(costs) – IFRS 9 fair value accounting | — |  | 140,056 |  | (2,993) |  | — |  | 137,063 |
Share-based payment expense | (5,136) |  | (4,703) |  | (8) |  | (4,852) |  | (14,699) |
Depreciation of tangible assets | (1,727) |  | (2,526) |  | (4) |  | (1,588) |  | (5,845) |
Amortization of ROU assets | — |  | (1,283) |  | — |  | (1,764) |  | (3,047) |
Amortization of intangible assets | — |  | — |  | (1) |  | — |  | (1) |
Taxation | — |  | — |  | — |  | 55,719 |  | 55,719 |
Income/(loss) for the year | (121,118) |  | 99,075 |  | (5,085) |  | (9,936) |  | (37,065) |
Other comprehensive income/(loss) | — |  | — |  | — |  | (379) |  | (379) |
Total comprehensive income/(loss) for the year | (121,118) |  | 99,075 |  | (5,085) |  | (10,316) |  | (37,444) |
Total comprehensive income/(loss) attributable to: |  |  |  |  |
Owners of the Company | (121,118) |  | 85,471 |  | (4,755) |  | (10,331) |  | (50,733) |
Non-controlling interests | — |  | 13,604 |  | (330) |  | 15 |  | 13,290 |
| December 31, 2022 $000s
Consolidated Statements of Financial Position: |  |  |  |  |
Total assets | 51,599 |  | 35,341 |  | — |  | 615,707 |  | 702,647 |
Total liabilities 1 | 271,186 |  | 76,635 |  | — |  | (192,763) |  | 155,057 |
Net assets/(liabilities) | (219,587) |  | (41,294) |  | — |  | 808,470 |  | 547,589 |
1 Parent Company and Other Includes eliminations of intercompany liabilities between the Parent Company and the reportable segments in the amount of $255.5 million.
| 2021
| Internal $000s | Controlled Founded Entities $000s | Non-Controlled Founded Entities $000s | Parent Company & Other $000s | Consolidated $000s
Consolidated Statements of Comprehensive Income/(Loss) |  |  |  |  |
Contract revenue | 8,129 |  | 1,500 |  | 115 |  | 235 |  | 9,979 |
Grant revenue | 1,253 |  | 6,156 |  | — |  | — |  | 7,409 |
Total revenue | 9,382 |  | 7,656 |  | 115 |  | 235 |  | 17,388 |
General and administrative expenses | (8,673) |  | (17,504) |  | (3,225) |  | (27,797) |  | (57,199) |
Research and development expenses | (65,444) |  | (40,667) |  | (3,116) |  | (1,244) |  | (110,471) |
Total Operating expenses | (74,118) |  | (58,171) |  | (6,341) |  | (29,041) |  | (167,671) |
Other income/(expense): |  |  |  |  |
Gain/(loss) on investment held at fair value | — |  | — |  | — |  | 179,316 |  | 179,316 |
Realized loss on sale of investments | — |  | — |  | — |  | (20,925) |  | (20,925) |
Other income/(expense) | — |  | 70 |  | — |  | 1,523 |  | 1,593 |
Total other income/(expense) | (1) |  | 70 |  | — |  | 159,914 |  | 159,983 |
Net finance income/(costs) | (16) |  | 7,528 |  | (784) |  | (1,679) |  | 5,050 |
Share of net income/(loss) of associate accounted for using the equity method | — |  | — |  | — |  | (73,703) |  | (73,703) |
Income/(loss) before taxes | (64,753) |  | (42,917) |  | (7,010) |  | 55,727 |  | (58,953) |
(Loss)/income before taxes pre IFRS 9 fair value accounting, finance costs – subsidiary preferred shares, share-based payment expense, depreciation of tangible assets and amortization of intangible assets | (60,368) |  | (44,335) |  | (6,248) |  | 63,628 |  | (47,323) |
Finance income/(costs) – IFRS 9 fair value accounting | — |  | 10,322 |  | (716) |  | — |  | 9,606 |
Share-based payment expense | (3,066) |  | (6,224) |  | (32) |  | (4,628) |  | (13,950) |
Depreciation of tangible assets | (1,319) |  | (1,506) |  | (12) |  | (1,510) |  | (4,347) |
Amortization of ROU assets | — |  | (1,174) |  | — |  | (1,764) |  | (2,938) |
Amortization of intangible assets | — |  | — |  | (2) |  | — |  | (2) |
Taxation | — |  | — |  | — |  | (3,756) |  | (3,756) |
Income/(loss) for the year | (64,753) |  | (42,917) |  | (7,010) |  | 51,971 |  | (62,709) |
Other comprehensive income/(loss) | — |  | — |  | — |  | — |  | — |
Total comprehensive income/(loss) for the year | (64,753) |  | (42,917) |  | (7,010) |  | 51,971 |  | (62,709) |
Total comprehensive income/(loss) attributable to: |  |  |  |  |
Owners of the Company | (64,657) |  | (41,283) |  | (6,574) |  | 51,956 |  | (60,558) |
Non-controlling interests | (96) |  | (1,634) |  | (436) |  | 15 |  | (2,151) |
| December 31, 2021 $000s
Consolidated Statements of Financial Position: |  |  |  |  |
Total assets | 125,726 |  | 64,508 |  | 1,765 |  | 754,007 |  | 946,006 |
Total liabilities 1 | 228,789 |  | 209,212 |  | 19,645 |  | (95,787) |  | 361,859 |
Net (liabilities)/assets | (103,063) |  | (144,704) |  | (17,880) |  | 849,794 |  | 584,147 |
1 Parent Company and Other Includes eliminations of intercompany liabilities between the Parent Company and the reportable segments in the amount of $233.3 million. The proportion of net assets shown above that is attributable to non-controlling interest is disclosed in Note 18.
| 2020
| Internal $000s | Controlled Founded Entities $000s | Non-Controlled Founded Entities $000s | Parent Company & Other $000s | Consolidated $000s
Consolidated Statements of Comprehensive Loss |  |  |  |  |
Contract revenue | 5,297 |  | 896 |  | 93 |  | 2,054 |  | 8,341 |
Grant revenue | 1,563 |  | 1,864 |  | — |  | — |  | 3,427 |
Total revenue | 6,860 |  | 2,760 |  | 93 |  | 2,054 |  | 11,768 |
General and administrative expenses | (3,482) |  | (10,752) |  | (2,939) |  | (32,267) |  | (49,440) |
Research and development expenses | (45,346) |  | (33,152) |  | (3,128) |  | (234) |  | (81,859) |
Total operating expense | (48,828) |  | (43,904) |  | (6,067) |  | (32,500) |  | (131,299) |
Other income/(expense): |  |  |  |  |
Gain/(loss) on investment held at fair value | — |  | — |  | — |  | 232,674 |  | 232,674 |
Realized loss on sale of investments | — |  | — |  | — |  | (54,976) |  | (54,976) |
Gain/(loss) on disposal of assets | (15) |  | (15) |  | — |  | — |  | (30) |
Other income/(expense) | — |  | 100 |  | — |  | 965 |  | 1,065 |
Other income/(expense) | (15) |  | 85 |  | — |  | 178,662 |  | 178,732 |
Net finance income/(costs) | 19 |  | (4,352) |  | (852) |  | (930) |  | (6,115) |
Share of net income/(loss) of associate accounted for using the equity method | — |  | — |  | — |  | (34,117) |  | (34,117) |
Income/(loss) before taxes | (41,964) |  | (45,410) |  | (6,826) |  | 113,170 |  | 18,969 |
(Loss)/income before taxes pre IAS 39 fair value accounting, finance costs – subsidiary preferred shares, share-based payment expense, depreciation of tangible assets and amortization of intangible assets | (38,349) |  | (36,736) |  | (5,866) |  | 121,644 |  | 40,694 |
Finance income/(costs) – IFRS 9 fair value accounting | — |  | (3,492) |  | (859) |  | — |  | (4,351) |
Share-based payment expense | (2,762) |  | (2,469) |  | (83) |  | (5,405) |  | (10,718) |
Depreciation of tangible assets | (854) |  | (1,528) |  | (17) |  | (1,547) |  | (3,945) |
Amortization of ROU assets | — |  | (1,186) |  | — |  | (1,523) |  | (2,709) |
Amortization of intangible assets | — |  | — |  | (1) |  | — |  | (1) |
Taxation | — |  | (1) |  | — |  | (14,400) |  | (14,401) |
Income/(loss) for the year | (41,964) |  | (45,411) |  | (6,826) |  | 98,769 |  | 4,568 |
Other comprehensive income/(loss) | — |  | — |  | — |  | 469 |  | 469 |
Total comprehensive income/(loss) for the year | (41,964) |  | (45,411) |  | (6,826) |  | 99,238 |  | 5,037 |
Total comprehensive income/(loss) attributable to: |  |  |  |  |
Owners of the Company | (41,773) |  | (44,506) |  | (6,519) |  | 99,253 |  | 6,454 |
Non-controlling interests | (191) |  | (905) |  | (306) |  | (15) |  | (1,417) |

X
- Definition The disclosure of operating segments. [Refer: Operating segments [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2022-03-24 -Paragraph 23 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfOperatingSegmentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Segment Information [Abstract] + References No definition available. + Details
Name: | ptv_SegmentInformationAbstract
Namespace Prefix: | ptv_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration